Amgen (AMGN) PT Raised to $375 at Jefferies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- S&P 500, Dow futures muted after big bank earnings, chip slide weighs
- Oil prices ease as traders monitor Russian diesel deal, Saudi attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
Tweet
Share
E-mailGet Alerts AMGN Hot Sheet
Price: $417.57 --0%
Rating Summary:
18 Buy, 20 Hold, 5 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 15 | New: 32
Rating Summary:
18 Buy, 20 Hold, 5 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 15 | New: 32
Join SI Premium – FREE
Jefferies analyst Michael Yee raised the price target on Amgen (NASDAQ: AMGN) to $375.00 (from $345.00) while maintaining a Buy rating.
You May Also Be Interested In
- Amgen (AMGN) PT Lowered to $415 at BMO Capital
- Amgen (AMGN) PT Lowered to $430 at Wells Fargo
- Amgen (AMGN) PT Raised to $470 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
